141 related articles for article (PubMed ID: 22578786)
21. Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma2 ligands.
Couture S; Debonnel G
Synapse; 1998 May; 29(1):62-71. PubMed ID: 9552175
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers.
Bergkemper M; Schepmann D; Wünsch B
ChemMedChem; 2021 Apr; 16(7):1184-1197. PubMed ID: 33332704
[TBL] [Abstract][Full Text] [Related]
23. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines.
Moltzen EK; Perregaard J; Meier E
J Med Chem; 1995 May; 38(11):2009-17. PubMed ID: 7783132
[TBL] [Abstract][Full Text] [Related]
24. Combination of two pharmacophoric systems: synthesis and pharmacological evaluation of spirocyclic pyranopyrazoles with high σ₁ receptor affinity.
Schläger T; Schepmann D; Lehmkuhl K; Holenz J; Vela JM; Buschmann H; Wünsch B
J Med Chem; 2011 Oct; 54(19):6704-13. PubMed ID: 21859078
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of bridged piperazines with sigma receptor affinity.
Weigl M; Wünsch B
Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073
[TBL] [Abstract][Full Text] [Related]
26. Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity.
Banister SD; Moussa IA; Jorgensen WT; Chua SW; Kassiou M
Bioorg Med Chem Lett; 2011 Jun; 21(12):3622-6. PubMed ID: 21555222
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands.
Moussa IA; Banister SD; Beinat C; Giboureau N; Reynolds AJ; Kassiou M
J Med Chem; 2010 Aug; 53(16):6228-39. PubMed ID: 20662542
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
29. 1'-Benzyl-3,4-dihydrospiro[2H-1- benzothiopyran-2,4'-piperidine] (spipethiane), a potent and highly selective sigma1 ligand.
Quaglia W; Giannella M; Piergentili A; Pigini M; Brasili L; Di Toro R; Rossetti L; Spampinato S; Melchiorre C
J Med Chem; 1998 May; 41(10):1557-60. PubMed ID: 9572880
[No Abstract] [Full Text] [Related]
30. Pd-catalyzed direct C-H bond functionalization of spirocyclic σ1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the σ1 receptor.
Meyer C; Schepmann D; Yanagisawa S; Yamaguchi J; Dal Col V; Laurini E; Itami K; Pricl S; Wünsch B
J Med Chem; 2012 Sep; 55(18):8047-65. PubMed ID: 22913577
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediam ines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes.
de Costa BR; Dominguez C; He XS; Williams W; Radesca L; Bowen W
J Med Chem; 1992 Nov; 35(23):4334-43. PubMed ID: 1447735
[TBL] [Abstract][Full Text] [Related]
32. Pharmacophore models and development of spirocyclic ligands for σ1 receptors.
Wunsch B
Curr Pharm Des; 2012; 18(7):930-7. PubMed ID: 22288413
[TBL] [Abstract][Full Text] [Related]
33. Substituted benzylaminoalkylindoles with preference for the sigma2 binding site.
Mamolo MG; Zampieri D; Zanette C; Florio C; Collina S; Urbano M; Azzolina O; Vio L
Eur J Med Chem; 2008 Oct; 43(10):2073-81. PubMed ID: 18069094
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety.
Bergkemper M; Kronenberg E; Thum S; Börgel F; Daniliuc C; Schepmann D; Nieto FR; Brust P; Reinoso RF; Alvarez I; Wünsch B
J Med Chem; 2018 Nov; 61(21):9666-9690. PubMed ID: 30350997
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological evaluation of a potent and selective σ1 receptor antagonist with high antiallodynic activity.
Utech T; Köhler J; Buschmann H; Holenz J; Vela JM; Wünsch B
Arch Pharm (Weinheim); 2011 Jul; 344(7):415-21. PubMed ID: 21598296
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationships of N-(3-phenylpropyl)-N'-benzylpiperazines: Potent ligands for sigma1 and sigma2 receptors.
Nahas RI; Lever JR; Lever SZ
Bioorg Med Chem; 2008 Jan; 16(2):755-61. PubMed ID: 18029187
[TBL] [Abstract][Full Text] [Related]
37. Novel sigma receptor ligands: synthesis and biological profile.
Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
[TBL] [Abstract][Full Text] [Related]
38. Novel analogs of the sigma receptor ligand BD1008 attenuate cocaine-induced toxicity in mice.
Matsumoto RR; Gilmore DL; Pouw B; Bowen WD; Williams W; Kausar A; Coop A
Eur J Pharmacol; 2004 May; 492(1):21-6. PubMed ID: 15145701
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of new bifunctional sigma-1 selective ligands with antioxidant activity.
Prezzavento O; Arena E; Parenti C; Pasquinucci L; Aricò G; Scoto GM; Grancara S; Toninello A; Ronsisvalle S
J Med Chem; 2013 Mar; 56(6):2447-55. PubMed ID: 23470245
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Structure-Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety.
Kronenberg E; Weber F; Brune S; Schepmann D; Almansa C; Friedland K; Laurini E; Pricl S; Wünsch B
J Med Chem; 2019 Apr; 62(8):4204-4217. PubMed ID: 30939014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
